Ideaya Biosciences Inc. IDYA
$30.21
▲ +0.49% 24H
About
Ideaya Biosciences Inc. is a precision medicine oncology company that discovers and develops targeted therapeutics for patient populations identified through molecular diagnostics. Its pipeline features IDE196, a protein kinase C inhibitor in Phase 2/3 clinical trials for cancers with GNAQ or GNA11 mutations; IDE397, a…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees145
TickerIDYA
Statistics
Market Cap$2.65B
Revenue (TTM)$218.7M
Net Income-$113.7M
Net Margin-52.0%
EPS$-1.28
P/E-22.54
P/S12.11
P/B2.70
EV/EBITDA-10.47
ROE-14.3%
Dividend Yield—
Price$30.21
Data: Twelve Data · Revenue = mcap / P/S